The doctor allegedly targeted some patients more than ten times, treating them again and again with procedures that were not medically necessary. 

“The cardiovascular community has lost an inspiring leader and a man whose warmth and generosity profoundly touched all those who knew him," the European Society of Cardiology said in a statement. 

The company and one of its subsidiaries would allegedly confuse clinicians and have them bill government programs for cardiac monitoring services that were more expensive than what they needed. This settlement resolves those allegations. 

While GLP-1 drugs were originally developed to treat diabetes, researchers keep finding additional ways these medications can potentially benefit patients.

“We identified a problem in cardiology,” one cardiologist explained. “Heart imaging has made remarkable progress in recent decades, but the electrics of the heart have eluded us."

Abbott's HeartMate 3 LVAD is the only FDA-approved device of its kind currently available in the United States. Should reports of adverse events worry cardiologists? Or are they to be expected when treating such a vulnerable patient population?

A hybrid approach may increase the risk of certain adverse events, according to a new meta-analysis focused on long-term outcomes. 

Revisit some of the year's biggest trends in the diagnosis, treatment and prevention of cardiovascular disease. 

João Cavalcante, MD, spoke at RSNA 2023 about key topics and tried to get more radiologists interested in cardiac imaging.

Congress has already adjourned for the year without taking action, but U.S. medical societies are hoping relief from significant Medicare cuts will arrive in early 2024.